A Novel Multipurpose Monoclonal Antibody for Evaluating Human C-Met Expression in Preclinical and Clinical Settings

Applied Immunohistochemistry and Molecular Morphology - United States
doi 10.1097/pai.0b013e3181816ae2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Preclinical Characterization of a Novel Monoclonal Antibody NEO-201 for the Treatment of Human Carcinomas

Frontiers in Immunology
AllergyImmunology
2018English

A Novel One-Armed Anti-C-Met Antibody Inhibits Glioblastoma Growth in Vivo

Clinical Cancer Research
Cancer ResearchOncology
2006English

ABBV-399, a C-Met Antibody–Drug Conjugate That Targets Both MET –Amplified and C-Met–Overexpressing Tumors, Irrespective of MET Pathway Dependence

Clinical Cancer Research
Cancer ResearchOncology
2016English

Experimental Study on the Regulation of Erlotinib-Induced Radiosensitization With an Anti-C-Met Monoclonal Antibody

Cancer Cell International
Cancer ResearchOncologyGenetics
2014English

A Human Monoclonal Antibody Against Pseudomonas Aeruginosa and the Possibility of Its Clinical Use

Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
1990English

Preclinical Antilymphoma Activity of a Humanized Anti-Cd40 Monoclonal Antibody, SGN-40

Cancer Research
Cancer ResearchOncology
2005English

Cloning and Expression of a Novel Murine Anti-Human Fas Antibody

Bioscience, Biotechnology and Biochemistry
Organic ChemistryApplied MicrobiologyMolecular BiologyBiochemistryAnalytical ChemistryMedicineBiotechnology
2000English

A Monoclonal Antibody Against Human Homocysteine-Induced Endoplasmic Reticulum Protein (Herp): A Useful Tool for Evaluating Endoplasmic Reticulum Stress

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2007English

Expression Vector-Derived Heterogeneity in a Therapeutic IgG4 Monoclonal Antibody

mAbs
AllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy